Breast cancer survivors and vitamin D: A review
Abstract
Recent evidence has suggested a role for vitamin D in breast cancer prevention and survival. Studies have reported an inverse relation between vitamin D intake and the risk of breast cancer, improvements in survival after a diagnosis of breast cancer in women with higher levels of vitamin D, and vitamin D insufficiency in up to 75% of women with breast cancer. Preclinical data have indicated that vitamin D affects up to 200 genes that influence cellular proliferation, apoptosis, angiogenesis, terminal differentiation of normal and cancer cells, and macrophage function. Vitamin D receptors have been found in up to 80% of breast cancers, and vitamin D receptor polymorphisms have been associated with differences in survival. Although ongoing studies have investigated a possible link between adequate levels of vitamin D and improved cancer prognosis, breast cancer survivors may derive additional, non–cancer-related benefits from adequate vitamin D levels, including improvements in bone mineral density, quality of life, and mood. Maintaining adequate vitamin D stores is recommended for breast cancer survivors throughout their lifetime.
Keywords: Breast cancer, Cancer survivor, Vitamin D, Vitamin D insufficiency
To access this article, please choose from the options below
Dr. Hines received research grants from Novartis, Sanofi-Aventis, and AstraZeneca for research in bone studies in patients with breast cancer using bisphosphonates (no relation to the present study).
PII: S0899-9007(09)00362-1
doi:10.1016/j.nut.2009.08.020
© 2010 Elsevier Inc. All rights reserved.
